Categories: News

WellSky® Introduces Advanced Home Health Visit Management Solution, Enabling Patient-Centered Care Planning at Scale

Leading home healthcare provider Intrepid USA leverages WellSky’s new predictive data analytics capabilities for enhanced visit utilization management

OVERLAND PARK, Kan.–(BUSINESS WIRE)–WellSky, a leading health and community care technology company, today announced new enhancements to its data analytics solution for home health. The new addition to the CareInsights™ solution suite, known as CareInsights Guidance, provides actionable visit utilization insights to balance the goals of care quality and patient health improvement with the need to control costs — and early adopters of the new capabilities are already realizing the benefits for their patients, staff, and business.

Deborah Barry, RN, CHPN, COS-C, BCHHC, vice president of clinical excellence and integrity for Intrepid USA Healthcare, Inc., found that the solution is well-suited to improve their care planning process, because it draws on the vast historical data of the WellSky Home Health client network and OASIS items already being captured on the patient record. Barry shared that as one of the largest home healthcare providers in the U.S. with 90 offices spanning 20 states, Intrepid USA has a history of high performance and continues to lower its hospitalization rate while reducing overall visit utilization — a critical factor in controlling costs.

“Guidance gives our clinical leaders confidence by providing a comprehensive view of the elements they need to help them make a decision on visit utilization,” said Barry. “It helps us understand each patient’s specific needs and how we can best support them, while ensuring we meet our margin requirements as a business. With CareInsights Guidance, it’s easy to play out the possibilities for different scenarios in the plan of care and refine our approach to achieve the patient’s goals for discharge.”

CareInsights Guidance is available as part of the WellSky CareInsights for Home Health solution, powered by algorithms based on historical data from more than 7 million home health patient episodes. This innovative technology delivers predictive insights on real-time patient hospitalization risk, social determinants of health, care setting suitability, Low Utilization Payment Adjustment (LUPA) risk and now, enhanced utilization management for improved care planning.

“Through collaboration with our home health clients, we recognized that case managers and other clinical leaders have to rely on too many different pieces of documentation to determine the appropriate visit frequency,” said WellSky Chief Analytics Officer Wes Little. “Our Guidance solution reduces that burden and takes some of the guesswork out of care planning. Home health providers can now automatically receive customized frequency guidelines in one simple view.”

The impact of CareInsights Guidance is further strengthened by recent enhancements made to the frequency management capabilities within WellSky’s core home health electronic health record (EHR) solution, WellSky Home Health. WellSky clients now have the data insights to develop more personalized, effective, and efficient plans of care using CareInsights Guidance, with the added benefit of streamlined frequency approval, scheduling, and documentation throughout the charting process.

As healthcare continues to shift from fee-for-service payment models to value-based care, it is increasingly important for providers to improve care quality and outcomes while keeping costs to a minimum. WellSky CareInsights for Home Health offers providers a competitive edge, with the supportive data needed to proactively manage their patient populations and effectively allocate resources for a more sustainable care delivery model.

Home health organizations that would like to learn more about WellSky CareInsights for Home Health and the new CareInsights Guidance solution can request a demonstration here.

About WellSky®

WellSky is a technology company leading the movement for intelligent, coordinated care worldwide. Our next-level software, analytics, and services power better outcomes and lower costs for stakeholders across the health and community care continuum. In today’s value-based care environment, WellSky helps providers, payers, health systems, and community organizations solve tough challenges, improve collaboration for growth, harness the power of data analytics, and achieve better outcomes by further connecting clinical and social care. WellSky serves more than 20,000 client sites around the world — including the largest hospital systems, blood banks, cell therapy labs, blood centers, home health and hospice franchises, post-acute providers, government agencies, and human services organizations. Informed by more than 40 years of providing software and expertise, WellSky anticipates clients’ needs and innovates relentlessly to ultimately help more people thrive. For more information, visit WellSky.com.

About Intrepid USA Healthcare Services, LLC

Intrepid USA Healthcare Services, LLC is a leading, private equity-backed provider of affordable, personalized, patient- and family-centered healthcare in the home, including personal care, home health, therapy, palliative care, and at-home hospice care services. With over 50 years of experience in delivering high quality home healthcare in rural, suburban, and non-urban markets across the United States and over 2,000 employees across 90 offices in 20 states, Intrepid USA is the twelfth-largest home healthcare company in the nation. Intrepid USA collaborates with the patient, their family, and their healthcare provider to develop a personalized care plan to match each patient’s unique needs, resulting in better outcomes, reduced hospitalizations, and enhanced quality of life.

Contacts

Media Contact
Emma Mulvaney

Phone: 617.401.3131

Email: emma.mulvaney@allisonpr.com

Staff

Recent Posts

Bemax Announces Financial Results for Fiscal Fourth Quarter Ended May 31, 2024

- Revenue increase of over 600%Dallas, Georgia--(Newsfile Corp. - July 2, 2024) - Bemax Inc.…

3 hours ago

1933 Industries Reports Profit in Q3 2024 Financials

VANCOUVER, BC / ACCESSWIRE / July 2, 2024 / 1933 Industries Inc. (the "Company" or…

3 hours ago

Myriad Genetics Earns 2024 Great Place To Work® Certification™

SALT LAKE CITY, July 02, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a…

3 hours ago

Scilex Holding Company to Ring Nasdaq Closing Bell on Friday, July 5th at 4:00PM ET at the Nasdaq MarketSite in Times Square, New York

The ceremony will be held in celebration of Scilex’s launch of GLOPERBA®, an innovative non-opioid…

3 hours ago

Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024

July 2, 2024 Biodexa Pharmaceuticals PLC Positive Phase 1 Clinical Data of MTX110 in DMG…

3 hours ago